Malignant Pleural Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Pleural Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology
A not-yet-recruiting trial from University of Kansas Medical Center aims to comprehensively map oncogenomic profiles in thoracic and head-an…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
A National Cancer Institute-supported clinical trial is evaluating cell changes in blood and tissue for cancers of the lung, esophagus, and …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma [Phase 3]
This entry notes a Phase 3 trial evaluating MEDI5752 in combination with carboplatin and pemetrexed for unresectable malignant pleural mesot…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma [NA]
A clinical trial evaluating hemithoracic irradiation using proton therapy in malignant pleural mesothelioma. The study is currently recruiti…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating Volrustomig as monotherapy or in combination with anti-cancer agents across multiple advanced/metastatic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma [Phase 1]
Phase 1 study evaluating pembrolizumab in combination with radiation therapy for malignant pleural mesothelioma; the trial is currently not …
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma [NA]
Clinical trial NCT03269227 assessing accelerated hypofractionated radiotherapy for malignant pleural mesothelioma is currently active but no…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers [NA]
A Dana-Farber Cancer Institute-led trial is recruiting to validate prognostic biomarkers for malignant pleural mesothelioma using prospectiv…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) [Phase 1]
This clinical trial update notes a Phase 1 study evaluating pembrolizumab in combination with chemotherapy and image-guided surgery for mali…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating autologous T cells engineered to target mesothelin in malignant pleural mesothelioma. The study is …
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: The IMmunotherapy Pleural 5-ALA PDT [Phase 2]
Phase 2 clinical trial evaluating 5-ALA photodynamic therapy for malignant pleural mesothelioma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma [NA]
A clinical trial is evaluating the use of electronic nose (E-Nose) technology to measure treatment response in malignant pleural mesotheliom…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma [Phase 1]
Clinical trial update for Phase 1 study of Nivolumab plus chemotherapy followed by surgery in malignant pleural mesothelioma; the trial is c…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study of NX-1607 in Adults With Advanced Malignancies [Phase 1]
A Phase 1 study evaluating NX-1607 in adults with advanced malignancies is actively recruiting across multiple tumor types, including ovaria…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Immune Microenvironment and Gene Expression Profiling in Mesothelioma
A clinical trial update describes a study evaluating the immune microenvironment and gene expression profiling in mesothelioma, focusing on …
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Gavo-cel (TC-210), a mesothelin-targeted therapy, in patients with advanced mesothelin-expressing cancer…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access
The SPECTAlung thoracic-tumor screening program has completed, documenting screening patients with lung cancer, malignant pleural mesothelio…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma [Phase 2]
Phase 2 clinical trial evaluating pleurectomy/decortication with neoadjuvant/adjuvant chemotherapy and pleural-intensity modulated radiation…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study [Phase 1, Phase 2]
This study investigates NECIM, a Phase 1/2 feasibility trial of neoadjuvant chemotherapy plus immunotherapy for selected inoperable pleural …
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: CT-95 in Advanced Cancers Associated With Mesothelin Expression [Phase 1]
Phase 1 trial CT-95 for mesothelin-expressing tumors is currently recruiting across multiple indications, including epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma [Phase 1]
This is a Phase 1 clinical trial evaluating a mesothelin-targeted CAR T-cell therapy in malignant pleural mesothelioma. The study status is …
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma
This clinical trial update describes the SMART trial evaluating surgery after radiation therapy for resectable malignant pleural mesotheliom…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma [Phase 2]
This is an update on a Phase 2 clinical trial evaluating neoadjuvant immune checkpoint blockade for patients with resectable malignant pleur…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma [Phase 2]
Phase 2 trial evaluating first-line sintilimab in combination with anlotinib and platinum doublet chemotherapy for malignant pleural mesothe…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma [Phase 2]
A Phase 2 clinical trial studying pembrolizumab plus chemotherapy with lenvatinib for malignant pleural mesothelioma is currently recruiting…